Safety and Tolerability of Kiddi® Pharmaton Fizz Effervescent Tablets in Children

Inclusion Criteria: * Children of both sexes aged between 6 and 14 years, inclusive * Children, healthy or during convalescence, for which prevention or treatment of marginal vitamin deficits is indicated * Willingness of the children and parents to give their written informed consent, according to Good Clinical Practice and local regulations * Pregnant children will not be excluded Exclusion Criteria: * Has taken medications containing vitamins A or D, retinoids, or iron during the 4 weeks preceding the study enrolment * Pre-treatment (less than 2 weeks prior the inclusion in this trial) and/or concomitant treatment with any drug that may influence the trial symptomatology, and may interfere with the evaluation of the safety of the test drug * Participation in other clinical trials within the last 4 weeks and concurrent participation in another clinical trial * Relevant allergy or kown hypersensitivity to one of the ingredients of the investigational drug * Has any serious disorder that may interfere with the participation to the trial * Malabsorption syndrome, liver and/or renal diseases or juvenile diabetes * Increased calcium blood concentration, or an increased calcium-excretion * Evident states of protein deficiency * Presence of lysinemia (defect of the enzyme lysine ketoglutarate reductase)